Amundson, C.J.; Knight, R.; Ybarra, G.M.; Turgeon, J.; Bingham, J.M.
Mitigating the Risk of Adverse Effects Related to Augmentation Therapy for Resistant Major Depressive Disorder: A Case Report. Medicina 2022, 58, 438.
https://doi.org/10.3390/medicina58030438
AMA Style
Amundson CJ, Knight R, Ybarra GM, Turgeon J, Bingham JM.
Mitigating the Risk of Adverse Effects Related to Augmentation Therapy for Resistant Major Depressive Disorder: A Case Report. Medicina. 2022; 58(3):438.
https://doi.org/10.3390/medicina58030438
Chicago/Turabian Style
Amundson, Collin J., Robert Knight, Georgina M. Ybarra, Jacques Turgeon, and Jennifer M. Bingham.
2022. "Mitigating the Risk of Adverse Effects Related to Augmentation Therapy for Resistant Major Depressive Disorder: A Case Report" Medicina 58, no. 3: 438.
https://doi.org/10.3390/medicina58030438
APA Style
Amundson, C. J., Knight, R., Ybarra, G. M., Turgeon, J., & Bingham, J. M.
(2022). Mitigating the Risk of Adverse Effects Related to Augmentation Therapy for Resistant Major Depressive Disorder: A Case Report. Medicina, 58(3), 438.
https://doi.org/10.3390/medicina58030438